令人悲伤 发表于 2025-3-28 17:24:45
Florian Kuchenbauer,Johannes Bloehdorn,Lars Bullinger,Thorsten Zenz赞成你 发表于 2025-3-28 19:06:58
http://reply.papertrans.cn/64/6329/632819/632819_42.pngNAV 发表于 2025-3-28 23:38:49
http://reply.papertrans.cn/64/6329/632819/632819_43.pngpacific 发表于 2025-3-29 03:04:50
MicroRNAs in Cancer (An Overview),, prognostic stratification, and drug-response prediction. MiRNAs also emerged as circulating markers, which may become valuable for early diagnosis and follow-up investigations. If we consider that studies on miRNAs in cancer therapy have already produced important results, in just few years, miRNACupping 发表于 2025-3-29 10:48:33
http://reply.papertrans.cn/64/6329/632819/632819_45.pngCountermand 发表于 2025-3-29 13:00:59
http://reply.papertrans.cn/64/6329/632819/632819_46.png时代 发表于 2025-3-29 18:55:04
http://reply.papertrans.cn/64/6329/632819/632819_47.png冰河期 发表于 2025-3-29 20:49:51
MicroRNAs in Esophageal Cancer,ofiles can distinguish between BE and EAC. The . polycistron is up-regulated progressively at successive stages of BE and EAC. . is up-regulated in high-grade dysplasia and EAC, and is a potential biomarker of progression from BE to EAC. A few mRNA targets of select miRNAs, including ., and ., have不妥协 发表于 2025-3-30 02:36:08
MicroRNAs in Bladder Cancer,ers specific to the tumor and/or patient can provide prognostic utility over that available from routine clinical features. Data have emerged documenting altered systemic miRNAs expression across a spectrum of cancers including urothelial carcinoma of the bladder. Examples include . (up-regulated),receptors 发表于 2025-3-30 05:31:51
http://reply.papertrans.cn/64/6329/632819/632819_50.png